Related Experiment Video
Updated: Aug 5, 2025

Erythrocyte Sedimentation Rate: A Physics-Driven Characterization in a Medical Context
Published on: March 24, 2023
Is Erythrocyte Sedimentation Rate Necessary for the Initial Diagnosis of Giant Cell Arteritis?
Michael S Hansen1, Oliver N Klefter1, Lene Terslev2
1Department of Ophthalmology, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Insights
Prompt diagnosis of giant cell arteritis (GCA) is crucial. Initial evaluation using platelet count and C-reactive protein (CRP) can expedite diagnosis, as erythrocyte sedimentation rate (ESR) offers no additional benefit.
Area of Science:
- Ophthalmology
- Rheumatology
- Clinical Diagnostics
Background:
- Giant cell arteritis (GCA) is a critical ophthalmological emergency requiring rapid diagnosis and treatment.
- Diagnostic delays in GCA can lead to severe complications, including vision loss.
Purpose of the Study:
- To evaluate the sequential diagnostic utility of platelet count, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) in suspected GCA cases.
- To determine if sequential biochemical testing can expedite the initial diagnostic decision-making process for GCA.
Main Methods:
- Retrospective cross-sectional study of 94 patients with suspected GCA.
- Analysis of diagnostic test accuracy statistics and odds ratios for platelet count, CRP, and ESR.
- GCA diagnosis was confirmed by expert consensus, including clinical findings and temporal artery biopsy.
Main Results:
- Patients with GCA showed significantly higher platelet counts, CRP, and ESR levels compared to those without GCA.
- Platelet count had low sensitivity (38%) and high specificity (88%).
- CRP (86% sensitivity, 56% specificity) and ESR (89% sensitivity, 47% specificity) showed high sensitivity but low specificity.
- Sequential analysis indicated that ESR provided no additional diagnostic value beyond platelet count and CRP.
Conclusions:
- Initial biochemical assessment for suspected GCA can effectively utilize platelet count and CRP.
- Incorporating platelet count and CRP early in the diagnostic workup allows for faster initial decision-making, without the need to await ESR results.
- This sequential approach can potentially reduce diagnostic delays in managing GCA.
Abstract:
Giant cell arteritis (GCA) is an ophthalmological emergency that can be difficult to diagnose and prompt treatment is vital. We investigated the sequential diagnostic value for patients with suspected GCA using three biochemical measures as they arrive to the clinician: first, platelet count, then C-reactive protein (CRP), and lastly, erythrocyte sedimentation rate (ESR). This retrospective cross-sectional study of consecutive patients with suspected GCA investigated platelet count, CRP, and ESR using diagnostic test accuracy statistics and odds ratios (ORs) in a sequential fashion. The diagnosis was established by experts at follow-up, considering clinical findings and tests including temporal artery biopsy. A total of 94 patients were included, of which 37 (40%) were diagnosed with GCA. Compared with those without GCA, patients with GCA had a higher platelet count (p < 0.001), CRP (p < 0.001), and ESR (p < 0.001). Platelet count demonstrated a low sensitivity (38%) and high specificity (88%); CRP, a high sensitivity (86%) and low specificity (56%); routine ESR, a high sensitivity (89%) and low specificity (47%); and age-adjusted ESR, a moderate sensitivity (65%) and moderate specificity (65%). Sequential analysis revealed that ESR did not provide additional value in evaluating risk of GCA. Initial biochemical evaluation can be based on platelet count and CRP, without waiting for ESR, which allows faster initial decision-making in GCA.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies